Hillhouse Investment Management, Ltd.'s Form 4 filing
BeOne Medicines Ltd. (ONC) · filed Jun 15, 2023
- Accession no.
- 0000902664-23-003603
- Filed
- Jun 15, 2023, 7:25 PM ET
- Trade date
- Jun 13-14, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hillhouse Investment Management, Ltd.CIK 0001510589 | 10% Owner |
| HHLR Advisors, Ltd.CIK 0001762304 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2023 | Ordinary Shares | SSaleDisposed | −611,000 | $211.45F1 | −$129,197,294.2 | 143,475,369 | Indirect | Price outlier |
| Jun 13, 2023 | Ordinary Shares | SSaleDisposed | −313,400 | HKD 128.43F2,F3Price in HKD, as filed | −HKD 40,251,058.9 | 143,161,969 | Indirect | Price outlier |
| Jun 14, 2023 | Ordinary Shares | SSaleDisposed | −273,728 | $207.72F1 | −$56,857,986.35 | 142,888,241 | Indirect | Price outlier |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The shares sold were in the form of ADS. The reported price is the price of each ADS sold, the price was paid in USD. Each ADS represents 13 Ordinary Shares.
Referenced by the price of 2 transactions in Table I.
- F2
The ordinary shares were sold through the Stock Exchange of Hong Kong, the price was paid in HKD.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from HKD127.75 to HKD128.5985, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ordinary shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.